| MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia SA Armstrong, JE Staunton, LB Silverman, R Pieters, ML den Boer, ... Nature genetics 30 (1), 41, 2002 | 2462 | 2002 |
| A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study ML Den Boer, M van Slegtenhorst, RX De Menezes, MH Cheok, ... The lancet oncology 10 (2), 125-134, 2009 | 1149 | 2009 |
| Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938, 2015 | 1058 | 2015 |
| FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors J O'Neil, J Grim, P Strack, S Rao, D Tibbitts, C Winter, J Hardwick, ... Journal of Experimental Medicine 204 (8), 1813-1824, 2007 | 811 | 2007 |
| A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial R Pieters, M Schrappe, P De Lorenzo, I Hann, G De Rossi, M Felice, ... The Lancet 370 (9583), 240-250, 2007 | 797 | 2007 |
| Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment A Holleman, MH Cheok, ML den Boer, W Yang, AJP Veerman, ... New England Journal of Medicine 351 (6), 533-542, 2004 | 738 | 2004 |
| L‐asparaginase treatment in acute lymphoblastic leukemia R Pieters, SP Hunger, J Boos, C Rizzari, L Silverman, A Baruchel, ... Cancer 117 (2), 238-249, 2011 | 682 | 2011 |
| Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance G Wei, D Twomey, J Lamb, K Schlis, J Agarwal, RW Stam, JT Opferman, ... Cancer cell 10 (4), 331-342, 2006 | 602 | 2006 |
| Biological and therapeutic aspects of infant leukemia A Biondi, G Cimino, R Pieters, CH Pui Blood 96 (1), 24-33, 2000 | 557 | 2000 |
| Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study BV Balgobind, SC Raimondi, J Harbott, M Zimmermann, TA Alonzo, ... Blood, 2009 | 523 | 2009 |
| Inhibition of FLT3 in MLL: validation of a therapeutic target identified by gene expression based classification SA Armstrong, AL Kung, ME Mabon, LB Silverman, RW Stam, ... Cancer cell 3 (2), 173-183, 2003 | 514 | 2003 |
| Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia PP Zenatti, D Ribeiro, W Li, L Zuurbier, MC Silva, M Paganin, J Tritapoe, ... Nature genetics 43 (10), 932, 2011 | 500 | 2011 |
| Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008 M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ... Leukemia 24 (3), 521, 2010 | 457 | 2010 |
| Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia I Homminga, R Pieters, AW Langerak, JJ de Rooi, A Stubbs, M Verstegen, ... Cancer cell 19 (4), 484-497, 2011 | 428 | 2011 |
| Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label … A Biondi, M Schrappe, P De Lorenzo, A Castor, G Lucchini, V Gandemer, ... The lancet oncology 13 (9), 936-945, 2012 | 398 | 2012 |
| Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood … R Pieters, H de Groot-Kruseman, V Van der Velden, M Fiocco, ... Journal of Clinical Oncology 34 (22), 2591-2601, 2016 | 376 | 2016 |
| NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ... Blood 118 (13), 3645-3656, 2011 | 353 | 2011 |
| In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties C le Viseur, M Hotfilder, S Bomken, K Wilson, S Röttgers, A Schrauder, ... Cancer cell 14 (1), 47-58, 2008 | 353 | 2008 |
| PHF6 mutations in T-cell acute lymphoblastic leukemia P Van Vlierberghe, T Palomero, H Khiabanian, J Van der Meulen, ... Nature genetics 42 (4), 338, 2010 | 349 | 2010 |
| Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands JM De Bont, B Van Der Holt, AW Dekker, P Sonneveld, R Pieters Leukemia 18 (12), 2032, 2004 | 340 | 2004 |
